Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Warrensville Heights › NPI 1235183542
Hospital

Cleveland Clinic Health System - East Region

Cleveland Clinic Health System - East Region was paid $31.44M by Medicaid between Jan 2018 and Dec 2024, across 299 billing codes. Its largest line is 99283, emergency room visit (moderate) — 15% of everything it billed.

33Billing provider infoCLEVELAND CLINIC HEALTH SYSTEM - EAST REGION
WARRENSVILLE HEIGHTS, OH 44122
33aNPI1235183542assigned 05/20/2006
28Total paid$31.44M
24GClaims765,894
24DCodes billed299
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Ohio

Rank by total paid#37 of 101
Median peer was paid$22.32M
This provider vs. median1.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official LARAWAY, DENNIS controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201880,579$2.47M
201969,875$2.31M
202049,292$2.91M
202163,452$3.68M
202271,739$3.21M
2023238,911$10.11M
2024incomplete192,046$6.73M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 15% 36,476 34,054 $4.86M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 33,781 30,977 $4.85M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 15% 31,105 27,112 $4.78M
96361 Intravenous infusion, hydration; each additional hour 11% 10,292 6,977 $3.42M
G0463 Hospital outpatient clinic visit for assessment and management of a patient 6.6% 24,501 18,914 $2.08M
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 3.8% 8,436 7,168 $1.19M
70450 Computed tomography, head or brain; without contrast material 3.1% 3,233 2,665 $974K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2.3% 4,350 3,924 $722K
G0378 Hospital observation service, per hour 2.2% 10,705 4,589 $685K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.9% 2,142 1,757 $602K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.6% 3,828 3,508 $507K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.5% 2,692 2,024 $462K
287 more codes
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 1.3% 1,747 $415K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.1% 2,559 $341K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,421 $298K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,078 $296K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 624 $291K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion <1% 3,950 $264K
80053 Comprehensive metabolic panel <1% 40,227 $263K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 1,932 $203K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 3,995 $189K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 630 $178K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 303 $157K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 463 $134K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 863 $125K
93970 <1% 658 $91K
11045 <1% 156 $86K
80048 Basic metabolic panel (calcium, ionized) <1% 7,218 $72K
71250 <1% 652 $69K
97161 <1% 1,851 $68K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 492 $68K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 648 $66K
93971 <1% 651 $64K
81513 <1% 388 $63K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,434 $62K
82805 <1% 1,480 $58K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 158 $57K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 231 $54K
84484 <1% 15,933 $51K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 41,902 $51K
93976 <1% 358 $51K
36415 Collection of venous blood by venipuncture <1% 68,296 $51K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 24,339 $50K
76830 Ultrasound, transvaginal <1% 760 $48K
71046 Radiologic examination, chest; 2 views <1% 3,792 $47K
97165 <1% 871 $46K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 6,488 $46K
80069 <1% 4,754 $44K
85027 <1% 12,343 $43K
76770 <1% 265 $40K
87631 <1% 202 $39K
93799 <1% 6,751 $39K
97113 <1% 537 $38K
84443 Thyroid stimulating hormone (TSH) <1% 2,875 $38K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 56 $35K
70498 <1% 85 $35K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 1,141 $33K
80061 Lipid panel <1% 2,495 $31K
71045 Radiologic examination, chest; single view <1% 11,161 $30K
43235 <1% 66 $30K
83735 <1% 18,114 $30K
86850 <1% 1,164 $30K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 48 $29K
96367 <1% 707 $29K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 15,768 $28K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 15,534 $27K
83036 Hemoglobin; glycosylated (A1C) <1% 2,321 $27K
97535 Self-care/home management training, each 15 minutes <1% 960 $26K
74018 <1% 715 $26K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,150 $25K
99214 Doctor's office visit, returning patient (more involved) <1% 1,002 $25K
12001 <1% 118 $24K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 257 $24K
97802 <1% 401 $24K
73630 <1% 1,111 $23K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 6,504 $23K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 559 $21K
71275 Computed tomographic angiography, chest, with contrast material <1% 56 $21K
77067 Screening mammography, bilateral, including computer-aided detection <1% 537 $21K
72125 Computed tomography, cervical spine; without contrast material <1% 1,308 $21K
97116 <1% 720 $20K
82962 <1% 13,523 $20K
99213 Doctor's office visit, returning patient (routine) <1% 926 $19K
73564 <1% 622 $18K
86780 <1% 2,682 $18K
99253 <1% 495 $18K
70491 <1% 41 $18K
70486 <1% 429 $18K
73030 <1% 925 $17K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 118 $17K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 797 $17K
10060 <1% 79 $16K
86900 <1% 1,189 $16K
96127 <1% 468 $16K
11043 <1% 96 $16K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 731 $15K
81001 <1% 29,110 $15K
82728 <1% 1,042 $14K
73610 <1% 959 $14K
86803 <1% 620 $14K
G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk <1% 13 $13K
72100 <1% 575 $13K
85610 <1% 11,573 $13K
90715 <1% 738 $13K
84702 <1% 1,025 $13K
73130 <1% 888 $12K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 1,223 $12K
J1756 Injection, iron sucrose, 1 mg <1% 369 $11K
82607 <1% 643 $11K
G0257 Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility <1% 42 $11K
73560 <1% 799 $11K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 1,262 $10K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 86 $10K
86140 <1% 1,260 $10K
83880 <1% 1,921 $10K
72197 <1% 31 $10K
99152 <1% 366 $10K
83540 <1% 1,119 $10K
84439 <1% 597 $9K
70496 <1% 145 $9K
73502 <1% 658 $9K
87340 <1% 562 $9K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 526 $8K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 3,035 $8K
76801 <1% 354 $8K
A9270 Non-covered item or service <1% 3,111 $8K
73110 <1% 572 $8K
82570 <1% 661 $8K
83550 <1% 1,105 $8K
74183 <1% 27 $7K
93017 <1% 104 $7K
97150 Therapeutic procedure(s), group (2 or more individuals) <1% 301 $7K
43245 <1% 15 $6K
99221 <1% 555 $6K
96375 Therapeutic injection; each additional sequential IV push <1% 5,610 $6K
86901 <1% 1,189 $6K
96376 <1% 3,195 $6K
82550 <1% 2,591 $6K
99232 Hospital visit by a doctor, follow-up day <1% 457 $5K
80076 <1% 630 $5K
83970 <1% 166 $5K
98927 <1% 181 $5K
96368 <1% 154 $5K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,974 $5K
76857 <1% 368 $4K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 284 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 <1% 3,130 $4K
77063 Screening digital breast tomosynthesis, bilateral <1% 73 $4K
87086 Culture, bacterial; quantitative colony count, urine <1% 1,945 $4K
93321 <1% 17 $4K
84100 <1% 1,114 $4K
76536 <1% 21 $4K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 864 $4K
84153 <1% 232 $4K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 34 $4K
83690 <1% 5,997 $4K
82077 <1% 2,487 $4K
82043 <1% 438 $3K
12011 <1% 16 $3K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 13 $3K
86706 <1% 215 $3K
98928 <1% 96 $3K
81025 <1% 19,825 $3K
82553 <1% 1,425 $3K
94760 <1% 3,389 $2K
83605 <1% 2,127 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 477 $2K
73590 <1% 223 $2K
87077 <1% 966 $2K
85652 <1% 332 $2K
99153 Mod sedat endo service >5yrs <1% 274 $2K
99215 Doctor's office visit, returning patient (complex) <1% 52 $2K
86703 <1% 1,997 $2K
93356 <1% 110 $2K
76642 <1% 14 $2K
85379 <1% 1,205 $2K
82330 <1% 1,656 $2K
98926 <1% 57 $2K
J1644 Injection, heparin sodium, per 1000 units <1% 6,940 $2K
82746 <1% 264 $2K
87040 <1% 614 $2K
92610 <1% 30 $2K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 4,154 $1K
84550 <1% 285 $1K
85730 <1% 1,607 $1K
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) <1% 506 $1K
82784 <1% 68 $1K
86480 <1% 16 $1K
85018 <1% 1,636 $964.91
82248 <1% 301 $949.48
80143 <1% 304 $909.52
87186 <1% 721 $909.40
73140 <1% 72 $852.03
84132 <1% 1,725 $829.95
92526 <1% 22 $779.62
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,411 $749.25
87205 <1% 706 $749.05
83615 <1% 112 $740.38
97162 <1% 13 $736.90
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 12,597 $725.46
87522 Neg quan hep c or qual rna <1% 16 $715.05
82375 <1% 1,504 $691.33
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,550 $669.08
00731 <1% 751 $668.64
90686 <1% 83 $666.44
J1815 Injection, insulin, per 5 units <1% 162 $663.11
87481 <1% 309 $633.75
87070 <1% 349 $631.12
C9113 Injection, pantoprazole sodium, per vial <1% 421 $622.40
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 774 $603.97
90656 <1% 43 $580.08
84156 <1% 95 $562.26
83721 <1% 70 $545.00
99203 Doctor's office visit, new patient (routine) <1% 19 $523.60
80179 <1% 274 $507.16
83050 <1% 1,514 $460.73
82435 <1% 1,388 $455.00
84403 <1% 19 $450.70
73080 <1% 41 $422.47
73090 <1% 14 $417.35
87808 <1% 809 $413.47
86038 <1% 25 $409.69
Q3014 Telehealth originating site facility fee <1% 14 $389.58
80074 <1% 17 $332.75
94799 <1% 17 $326.17
80320 <1% 209 $297.43
82010 <1% 388 $284.77
84295 <1% 1,470 $270.16
85045 <1% 137 $263.42
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 452 $259.59
J1170 Injection, hydromorphone, up to 4 mg <1% 584 $250.57
J0780 Injection, prochlorperazine, up to 10 mg <1% 842 $243.41
83520 <1% 13 $223.39
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,169 $213.89
J2704 Injection, propofol, 10 mg <1% 5,523 $182.01
J3490 Unclassified drugs <1% 40 $169.09
83695 <1% 57 $156.04
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,688 $154.92
87430 <1% 402 $150.65
73552 <1% 37 $135.05
84165 <1% 13 $114.76
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 253 $105.14
J1650 Injection, enoxaparin sodium, 10 mg <1% 128 $103.60
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,639 $100.51
J2060 Injection, lorazepam, 2 mg <1% 552 $94.13
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 5,378 $91.19
81003 <1% 317 $84.46
84703 <1% 78 $82.46
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,613 $77.81
80164 <1% 28 $72.71
84155 <1% 16 $68.65
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 1,740 $65.07
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 159 $58.78
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 27 $58.01
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 905 $57.28
J2470 Injection, pantoprazole sodium, 40 mg <1% 147 $49.92
J1790 Injection, droperidol, up to 5 mg <1% 439 $48.56
88342 <1% 40 $48.31
J3480 Injection, potassium chloride, per 2 meq <1% 295 $47.44
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,878 $47.40
J0360 Injection, hydralazine hcl, up to 20 mg <1% 37 $44.30
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 1,961 $41.62
J2371 Injection, phenylephrine hydrochloride, 20 micrograms <1% 250 $31.88
84145 <1% 36 $28.65
J2920 Injection, methylprednisolone sodium succinate, up to 40 mg <1% 35 $25.28
J0690 Injection, cefazolin sodium, 500 mg <1% 950 $13.92
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 41 $13.82
71101 <1% 50 $11.75
Q9969 Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose <1% 464 $11.00
J1171 Injection, hydromorphone, 0.1 mg <1% 47 $9.19
J1596 Injection, glycopyrrolate, 0.1 mg <1% 174 $6.75
J3370 Injection, vancomycin hcl, 500 mg <1% 66 $5.16
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 58 $3.04
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 149 $2.18
99233 Hospital visit by a doctor, follow-up day (complex) 0% 30 $0.00
00811 0% 262 $0.00
87660 0% 26 $0.00
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 0% 158 $0.00
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg 0% 24 $0.00
3078F 0% 146 $0.00
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 0% 48 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 32 $0.00
87899 0% 27 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 27 $0.00
J2370 Injection, phenylephrine hcl, up to 1 ml 0% 116 $0.00
87480 0% 26 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 134 $0.00
74174 0% 14 $0.00
3074F 0% 181 $0.00
C1726 Catheter, balloon dilatation, non-vascular 0% 15 $0.00
C1889 Implantable/insertable device, not otherwise classified 0% 18 $0.00
C1769 Guide wire 0% 292 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 20 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 80 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 92 $0.00
00813 0% 78 $0.00
3079F 0% 41 $0.00
87510 0% 26 $0.00
00952 0% 18 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialLARAWAY, DENNIS (EXECUTIVE VP CHIEF FINANCE OFFICER)
Same official

Other billing entities under LARAWAY, DENNIS

Full network →

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.